{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:39:02Z","timestamp":1791182342247,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1093\/jac\/45.2.167","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:24:55Z","timestamp":1027722295000},"page":"167-173","source":"Crossref","is-referenced-by-count":89,"title":["Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates"],"prefix":"10.1093","volume":"45","author":[{"given":"P.","family":"Descheemaeker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chapelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hauchecorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wijdooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vandamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,2]]},"reference":[{"key":"key\n\t\t\t\t20170411032605_R1","doi-asserted-by":"crossref","unstructured":"Bisno, A. L. (1991). Group A streptococcal infections and acute rheumatic fever. New England Journal of Medicine325, 783\u201393.","DOI":"10.1056\/NEJM199109123251106"},{"key":"key\n\t\t\t\t20170411032605_R2","doi-asserted-by":"crossref","unstructured":"Bisno, A. L. & Stevens, D. L. (1996). Streptococcal infections of skin and soft tissues. New England Journal of Medicine334, 240\u20135.","DOI":"10.1056\/NEJM199601253340407"},{"key":"key\n\t\t\t\t20170411032605_R3","doi-asserted-by":"crossref","unstructured":"Demers, B., Simor, A. E., Vellend, H., Schlievert, P. M., Byrne, S., Jamieson, F. et al. (1993). Severe invasive group A streptococcal infections in Ontario, Canada: 1987\u20131991. Clinical Infectious Diseases16, 792\u2013800.","DOI":"10.1093\/clind\/16.6.792"},{"key":"key\n\t\t\t\t20170411032605_R4","doi-asserted-by":"crossref","unstructured":"Denny, F. W. (1994). A 45-year perspective on the streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clinical Infectious Diseases19, 1110\u201322.","DOI":"10.1093\/clinids\/19.6.1110"},{"key":"key\n\t\t\t\t20170411032605_R5","doi-asserted-by":"crossref","unstructured":"Stevens, D. L. (1992). Invasive group A streptococcus infections. Clinical Infectious Diseases14, 2\u201311.","DOI":"10.1093\/clinids\/14.1.2"},{"key":"key\n\t\t\t\t20170411032605_R6","doi-asserted-by":"crossref","unstructured":"Lowbury, E. J. L. & Hurst, L. (1959). The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. Journal of Clinical Pathology12, 163\u20139.","DOI":"10.1136\/jcp.12.2.163"},{"key":"key\n\t\t\t\t20170411032605_R7","doi-asserted-by":"crossref","unstructured":"Gerber, M. A. (1996). Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract. Pediatrics97, 971\u20135.","DOI":"10.1542\/peds.97.6.971"},{"key":"key\n\t\t\t\t20170411032605_R8","doi-asserted-by":"crossref","unstructured":"Nakae, M., Murai, T., Kaneko, Y. & Mitsuhashi, S. (1977). Drug resistance in Streptococcus pyogenes isolated in Japan. Antimicrobial Agents and Chemotherapy12, 427\u20138.","DOI":"10.1128\/AAC.12.3.427"},{"key":"key\n\t\t\t\t20170411032605_R9","doi-asserted-by":"crossref","unstructured":"Miyamoto, Y., Takizawa, K., Matsushima, A., Asai, Y. & Nakatsuka, S. (1978). Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Prevalence of resistance to erythromycin in Japan. Antimicrobial Agents and Chemotherapy13, 399\u2013404.","DOI":"10.1128\/AAC.13.3.399"},{"key":"key\n\t\t\t\t20170411032605_R10","doi-asserted-by":"crossref","unstructured":"Maruyama, S., Yoshioka, H., Fujita, K., Takimoto, M. & Satake, Y. (1979). Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. American Journal of Diseases of Children133, 1143\u20135.","DOI":"10.1001\/archpedi.1979.02130110051007"},{"key":"key\n\t\t\t\t20170411032605_R11","doi-asserted-by":"crossref","unstructured":"Sepp\u00e4l\u00e4, H., Klaukka, T., Lehtonen, R., Nenonen, E. & Huovinen, P. (1995). Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clinical Infectious Diseases21, 1378\u201385.","DOI":"10.1093\/clinids\/21.6.1378"},{"key":"key\n\t\t\t\t20170411032605_R12","doi-asserted-by":"crossref","unstructured":"Bass, J. W., Weisse, M. E., Plymyer, M. R., Murphy, S. & Eberly, B. J. (1994). Decline of erythromycin resistance of group A \u03b2-haemolytic streptococci in Japan. Comparison with worldwide reports. Archives of Pediatrics and Adolescent Medicine148, 67\u201371.","DOI":"10.1001\/archpedi.1994.02170010069016"},{"key":"key\n\t\t\t\t20170411032605_R13","doi-asserted-by":"crossref","unstructured":"Fujita, K., Murono, K., Yoshikawa, M. & Murai, T. (1994). Decline of erythromycin resistance of group A streptococci in Japan. Pediatric Infectious Disease Journal13, 1075\u20138.","DOI":"10.1097\/00006454-199412000-00001"},{"key":"key\n\t\t\t\t20170411032605_R14","doi-asserted-by":"crossref","unstructured":"Berman, S. (1991). Epidemiology of acute respiratory infections in children of developing countries. Reviews of Infectious Diseases13, Suppl. 6, 454\u201362.","DOI":"10.1093\/clinids\/13.Supplement_6.S454"},{"key":"key\n\t\t\t\t20170411032605_R15","doi-asserted-by":"crossref","unstructured":"Musher, D. M. (1992). Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clinical Infectious Diseases14, 801\u20137.","DOI":"10.1093\/clinids\/14.4.801"},{"key":"key\n\t\t\t\t20170411032605_R16","doi-asserted-by":"crossref","unstructured":"Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases15, 77\u201383.","DOI":"10.1093\/clinids\/15.1.77"},{"key":"key\n\t\t\t\t20170411032605_R17","doi-asserted-by":"crossref","unstructured":"Klugman, K. P. (1990). Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews3, 171\u201396.","DOI":"10.1128\/CMR.3.2.171"},{"key":"key\n\t\t\t\t20170411032605_R18","doi-asserted-by":"crossref","unstructured":"Doern, G. J., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy40, 1208\u201313.","DOI":"10.1128\/AAC.40.5.1208"},{"key":"key\n\t\t\t\t20170411032605_R19","doi-asserted-by":"crossref","unstructured":"Geslin, P., Buu-Hoi, A., Fremaux, A. & Acar, J. F. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970\u20131990. Clinical Infectious Diseases15, 95\u20138.","DOI":"10.1093\/clinids\/15.1.95"},{"key":"key\n\t\t\t\t20170411032605_R20","doi-asserted-by":"crossref","unstructured":"Leclercq, R. & Courvalin, P. (1991). Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy35, 1267\u201372, 2165 [Erratum].","DOI":"10.1128\/AAC.35.7.1267"},{"key":"key\n\t\t\t\t20170411032605_R21","doi-asserted-by":"crossref","unstructured":"Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy40, 2562\u20136.","DOI":"10.1128\/AAC.40.11.2562"},{"key":"key\n\t\t\t\t20170411032605_R22","doi-asserted-by":"crossref","unstructured":"Sepp\u00e4l\u00e4, H., Skurnik, M., Soini, H., Roberts, M. C. & Huovinen, P. (1998). A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrobial Agents and Chemotherapy42, 257\u201362.","DOI":"10.1128\/AAC.42.2.257"},{"key":"key\n\t\t\t\t20170411032605_R23","doi-asserted-by":"crossref","unstructured":"Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy40, 1817\u201324.","DOI":"10.1128\/AAC.40.8.1817"},{"key":"key\n\t\t\t\t20170411032605_R24","doi-asserted-by":"crossref","unstructured":"Sepp\u00e4l\u00e4, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy32, 885\u201391.","DOI":"10.1093\/jac\/32.6.885"},{"key":"key\n\t\t\t\t20170411032605_R25","doi-asserted-by":"crossref","unstructured":"Clancy, J., Petitpas, J., Dib-Hajj, F., Yuan, W., Cronan, M., Kamath, A. V. et al. (1996). Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Molecular Microbiology22, 867\u201379.","DOI":"10.1046\/j.1365-2958.1996.01521.x"},{"key":"key\n\t\t\t\t20170411032605_R26","unstructured":"National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411032605_R27","doi-asserted-by":"crossref","unstructured":"Pitcher, D. G., Saunders, N. A. & Owen, R. J. (1989). Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Letters in Applied Microbiology8, 151\u20136.","DOI":"10.1111\/j.1472-765X.1989.tb00262.x"},{"key":"key\n\t\t\t\t20170411032605_R28","doi-asserted-by":"crossref","unstructured":"Descheemaeker, P., Lammens, C., Pot, B., Vandamme, P. & Goossens, H. (1997). Evaluation of arbitrarily primed PCR analysis and pulsed field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine. International Journal of Systematic Bacteriology47, 555\u201361.","DOI":"10.1099\/00207713-47-2-555"},{"key":"key\n\t\t\t\t20170411032605_R29","doi-asserted-by":"crossref","unstructured":"Kaufhold, A., Podbielski, A., Baumgarten, G., Blokpoel, M., Top, J. & Schouls, L. (1994). Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiology Letters119, 19\u201325.","DOI":"10.1111\/j.1574-6968.1994.tb06861.x"},{"key":"key\n\t\t\t\t20170411032605_R30","doi-asserted-by":"crossref","unstructured":"Perez-Trallero, E., Urbieta, M., Montes, M., Ayestaran, I. & Marimon, J. M. (1998). Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. European Journal of Clinical Microbiology and Infectious Diseases17, 25\u201331.","DOI":"10.1007\/BF01584359"},{"key":"key\n\t\t\t\t20170411032605_R31","doi-asserted-by":"crossref","unstructured":"Orden, B., Perez-Trallero, E., Montes, M. & Martinez, R. (1998). Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatric Infection Disease Journal17, 470\u20133.","DOI":"10.1097\/00006454-199806000-00006"},{"key":"key\n\t\t\t\t20170411032605_R32","doi-asserted-by":"crossref","unstructured":"Cornaglia, G., Ligozzi, M., Mazzariol, A., Valentini, M., Orefici, G. & Fontana, R. (1996). Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993\u2013 1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerging Infectious Diseases2, 339\u201342.","DOI":"10.3201\/eid0204.960410"},{"key":"key\n\t\t\t\t20170411032605_R33","doi-asserted-by":"crossref","unstructured":"Cocuzza, C. E., Mattina, R., Mazzariol, A., Orefici, G., Rescaldani, R., Primavera, A. et al. (1997). High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microbial Drug Resistance3, 371\u20138.","DOI":"10.1089\/mdr.1997.3.371"},{"key":"key\n\t\t\t\t20170411032605_R34","doi-asserted-by":"crossref","unstructured":"Cocuzza, C. E., Blandino, G., Mattina, R., Nicoletti, F. & Nicoletti, G. (1997). Antibiotic susceptibility of Group A streptococci in 2 Italian cities: Milano and Catania. Microbial Drug Resistance3, 379\u201384.","DOI":"10.1089\/mdr.1997.3.379"},{"key":"key\n\t\t\t\t20170411032605_R35","doi-asserted-by":"crossref","unstructured":"Jasir, A. & Schal\u00e9n, C. (1998). Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes. Journal of Antimicrobial Chemotherapy41, 135\u20137.","DOI":"10.1093\/jac\/41.1.135"},{"key":"key\n\t\t\t\t20170411032605_R36","doi-asserted-by":"crossref","unstructured":"Kriebernegg, I., Feierl, G., Grisold, A. & Marth, E. (1998). In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarithromycin and azithromycin in Styria, Austria. Zentralblatt f\u00fcr Bakteriologie287, 33\u20139.","DOI":"10.1016\/S0934-8840(98)80139-4"},{"key":"key\n\t\t\t\t20170411032605_R37","doi-asserted-by":"crossref","unstructured":"Kataja, J., Huovinen, P., Muotiala, A., Vuopio-Varkila, J., Efstratiou, A., Hallas, G. et al. (1998). Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. Journal of Infectious Diseases177, 786\u20139.","DOI":"10.1086\/517809"},{"key":"key\n\t\t\t\t20170411032605_R38","doi-asserted-by":"crossref","unstructured":"Verhaegen, J., Glupczynski, Y., Verbist, L., Blogie, M., Verbiest, N., Vandeven, J. et al. (1995). Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980\u20131993. Clinical Infectious Diseases20, 1339\u201345.","DOI":"10.1093\/clinids\/20.5.1339"},{"key":"key\n\t\t\t\t20170411032605_R39","doi-asserted-by":"crossref","unstructured":"Barry, A. L., Fuchs, P. C. & Brown, S. D. (1998). Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin) and a lincosamide (clindamycin). Antimicrobial Agents and Chemotherapy42, 945\u20136.","DOI":"10.1128\/AAC.42.4.945"},{"key":"key\n\t\t\t\t20170411032605_R40","doi-asserted-by":"crossref","unstructured":"Shortridge, V. D., Flamm, R. K., Ramer, N., Beyer, J. & Tanaka, S. K. (1996). Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease26, 73\u20138.","DOI":"10.1016\/S0732-8893(96)00183-6"},{"key":"key\n\t\t\t\t20170411032605_R41","doi-asserted-by":"crossref","unstructured":"Johnston, N. J., De Azavedo, J. C., Kellner, J. D. & Low, D. E. (1998). Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy42, 2425\u20136.","DOI":"10.1128\/AAC.42.9.2425"},{"key":"key\n\t\t\t\t20170411032605_R42","doi-asserted-by":"crossref","unstructured":"Barry, A. L., Fuchs, P. C. & Brown, S. D. (1998). In vitro activities of the ketolide HMR 3647 against recent Gram-positive clinical isolates and Haemophilus influenzae. Antimicrobial Agents and Chemotherapy42, 2138\u201340.","DOI":"10.1128\/AAC.42.8.2138"},{"key":"key\n\t\t\t\t20170411032605_R43","unstructured":"Agouridas, C., Collette, P., Mauvais, P. & Chantot, J. F. (1995). RU 004: preliminary studies on the mechanism of action. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F170, p. 142. American Society for Microbiology, Washington, DC."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/45\/2\/167\/13057290\/JAC452167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T03:41:16Z","timestamp":1682221276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/45.2.167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2000,2]]},"published-print":{"date-parts":[[2000,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/45.2.167","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}